RTQA: Virtual EPID Standard Phantom Audit

A novel remote method for external dosimetric TPS-planned auditing of intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) for clinical trials using electronic portal imaging device (EPID) has been developed. The audit has been applied to multiple centers across Australia and New Zealand.

Primary Sponsor

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Trial Contact

qa@trog.com.au

Related Post

Alan Walker Cancer Care Centre team involved in ASPIRE trial
5 June, 2025

NT Cancer Centre Marks Milestone of Recruiting 300th patient to ASPIRE Registry

LATEST NEWS: 5 JUNE 2025 The Alan Walker Cancer

David, Jasmine and Susan Goode, re Kokoda Challenge to support TROG Cancer Research
27 May, 2025

Intrepid trekkers to take on Kokoda Challenge for TROG

LATEST NEWS: 27 May 2025 A team of five